BIOBASE shines at CACLP 2025: Opening a new chapter in IVD!

The 22nd CACLP concluded in Hangzhou on March 24, 2025. As a flagship event in the global IVD industry, CACLP 2025 attracted over 1,300 exhibitors from both domestic and international markets.

At this exhibition, BIOBASE showcased a range of innovative products and solutions in the fields of laboratory diagnostics, blood transfusion, neonatology and rehabilitation. With its technological strengths in intelligence, precision and diversification, the BIOBASE delivered a remarkable display of healthcare innovations, drawing widespread industry attention.

Among them, BIOBASE’s IVD products shone. The automatic chemistry analyzer, automatic chemiluminescence immunoassay system, and supporting reagents formed a high-efficiency testing matrix. The system covered over 100 test parameters, including tumor markers, hormones, and infectious diseases. Additionally, the auto ELISA processor enabled a seamless "sample-in, result-out" streamlined workflow, significantly improving testing efficiency.

With the advantages of a well-established product ecosystem and integrated solutions, the BIOBASE booth attracted a large number of industry insiders who stopped to engage in discussions. Many customers expressed a strong interest in collaboration.

BIOBASE will remain committed to its mission of "Service, Health, and Future," further investing in R&D and strengthening global cooperation to advance the in vitro diagnostics industry.